Article

Panoptx launches new logo, new models, new technology

Panoptx has launched a new logo with a stylized number 7, tied to a new brand (7EYE), along with a renewed emphasis on the treatment of dysfunctional tear syndrome (DTS) and servicing independent dispensaries that care for patients with DTS symptoms.

Pleasanton, CA-Panoptx has launched a new logo with a stylized number 7, tied to a new brand (7EYE), along with a renewed emphasis on the treatment of dysfunctional tear syndrome (DTS) and servicing independent dispensaries that care for patients with DTS symptoms.

Explaining the rationale behind the new name, Bob Hall, Panoptx president and chief executive officer, said, "We wanted a name with instant recognition, a logo that would stand out, a domain name that people could spell, a name with youthful energy and attitude. We found that combination with the 7EYE logo and brand.

The first Panoptx frames bearing the 7EYE logo are being introduced as 7EYE by Panoptx Limited Edition III series to the motorcycle market, where Panoptx first became a hit among Harley-Davidson riders.

"The introduction of 7EYE is the beginning of a new platform for product development," Hall continued.

"We are creating a solid foundation for brand expansion and sales growth, and with new styles and new technology in the pipeline, 7EYE will fuel that growth."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.